公开(公告)号：US11096916B2

公开(公告)日：2021-08-24

申请号：US16703501

申请日：2019-12-04

Applicant: NOVARTIS AG

Inventor： Therese Di Paolo ,  Dominik Feuerbach ,  Baltazar Gomez-Mancilla ,  Donald Johns

IPC: A61K31/198 ,  A61K31/444 ,  A61K45/06

Abstract: The invention concerns the use of a nicotinic acetylcholine receptor alpha 7 activators for the treatment, prevention or delay of progression of dyskinesia associated with dopamine agonist therapy in Parkinson's Disease.

公开(公告)号：US20210338621A1

公开(公告)日：2021-11-04

申请号：US17378136

申请日：2021-07-16

Applicant: NOVARTIS AG

Inventor： Therese Di Paolo ,  Dominik Feuerbach ,  Baltazar Gomez-Mancilla ,  Donald Johns

IPC: A61K31/198 ,  A61K45/06

Abstract: The invention concerns the use of a nicotinic acetylcholine receptor alpha 7 activators for the treatment, prevention or delay of progression of dyskinesia associated with dopamine agonist therapy in Parkinson's Disease.